Pía Garat
UruguayentrepreneurFemale7.0Global Dominance: 0.00%Pía Garat is a co-founder of Eolo Pharma, a biotechnology company based in Uruguay. She has been instrumental in the development of SANA, a groundbreaking medication designed to combat obesity, which has recently shown promising results in early clinical trials. Under her leadership, Eolo Pharma aims to provide innovative treatments that address obesity while emphasizing the need for behavioral changes in patients. Garat's work is celebrated as a significant milestone for Uruguay, marking the first time a drug of this kind has been developed entirely within the country.
Country presence
Recent news mentions
Pía Garat from Eolo Pharma highlights the need to strengthen entrepreneurial capital in the region.
el sector uruguayo que busca transformar la salud y ya cautivó a inversores como Sergio FogelUruguay· 2026-08-03
Pía Garat is a co-founder of Eolo Pharma, a startup that developed a drug for obesity and diabetes.
un repaso por los hitos del ecosistema emprendedor uruguayo en 2025 y las startups con mayor proyección para 2026 según los expertosUruguay· 2026-01-11
Pía Garat, co-founder of Eolo Pharma, indicated that the horizon for the drug's availability is about five years.
Cómo funciona el fármaco desarrollado por científicos uruguayos que promete efectos notables para combatir la obesidadUruguay· 2025-06-18
